In vitro activities of the ketolides ABT-773 and telithromycin and of three macrolides against genetically characterized isolates of Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae and Moraxella catarrhalis

被引：19
|
作者：
Schmitz, FJ
Schwarz, S
Milatovic, D
Verhoef, J
Fluit, AC
机构：
[1] Univ Dusseldorf, Inst Med Microbiol & Virol, D-40225 Dusseldorf, Germany
[2] Eijkman Winkler Inst Med Microbiol, Utrecht, Netherlands
[3] Bundesforschungsanstalt Landwirtschaft, Inst Tierzucht & Tierverhalten, Celle, Germany
来源：
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2002年 / 50卷 / 01期
关键词：
D O I：
10.1093/jac/dkf085
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：145 / 148
页数：4
相关论文
共 50 条
  • [21] Susceptibility of Canadian isolates of Haemophilus influenzae, Moraxella catarrhalis and Streptococcus pneumoniae to oral antimicrobial agents
    Blondeau, JM
    Vaughan, D
    Laskowski, R
    Borsos, S
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2001, 17 (06) : 457 - 464
  • [22] In-vitro activity of HMR 3647 against Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis and β-haemolytic streptococci
    Wootton, M
    Bowker, KE
    Janowska, A
    Holt, HA
    MacGowan, AP
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1999, 44 (04) : 445 - 453
  • [23] In vitro activity of a novel ketolide ABT-773 against invasive strains of Streptococcus pneumoniae
    Weiss, K
    de Azavedo, L
    Restieri, C
    Quach, C
    Laverdiere, M
    Rubin, E
    Gourdeaud, M
    Low, DE
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 (03) : 407 - 409
  • [24] The Activity of Fluoroquinolones and Other Antimicrobial Agents Against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
    Clyde Thornsberry
    P. Ogilvie
    H. P. Holley
    M. L. Hickey
    M. E. Jones
    I. A. Critchley
    D. F. Sahm
    [J]. Drugs, 1999, 58 : 346 - 348
  • [25] The activity of fluoroquinolones and other antimicrobial agents against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis
    Thornsberry, C
    Ogilvie, P
    Holley, HP
    Hickey, ML
    Jones, ME
    Critchley, IA
    Sahm, DF
    [J]. DRUGS, 1999, 58 (Suppl 2) : 346 - 348
  • [26] Mutant selection window of four quinolone antibiotics against clinical isolates of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis
    Nakai, Hajime
    Sato, Takumi
    Uno, Takashi
    Furukawa, Emiko
    Kawamura, Masato
    Takahashi, Hiroshi
    Watanabe, Akira
    Fujimura, Shigeru
    [J]. JOURNAL OF INFECTION AND CHEMOTHERAPY, 2018, 24 (02) : 83 - 87
  • [27] Oral antimicrobial susceptibilities of Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis isolates from Japanese children
    Nishi, J
    Yoshinaga, M
    Tokuda, K
    Masuda, K
    Masuda, R
    Kamenosono, A
    Manago, K
    Miyata, K
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2002, 20 (02) : 130 - 135
  • [28] Antimicrobial activity of innate immune molecules against Streptococcus pneumoniae, Moraxella catarrhalis and nontypeable Haemophilus influenzae
    Haa-Yung Lee
    Ali Andalibi
    Paul Webster
    Sung-Kyun Moon
    Karen Teufert
    Sung-Ho Kang
    Jian-Dong Li
    Mitsuyoshi Nagura
    Tomas Ganz
    David J Lim
    [J]. BMC Infectious Diseases, 4
  • [29] In vitro evaluation of a novel orally administered cephalosporin (Cefditoren) tested against 1249 recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae
    Jones, RN
    Biedenbach, DJ
    Croco, MAT
    Barrett, MS
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1998, 31 (04) : 573 - 578
  • [30] Benchmarking the in vitro activity of moxifloxacin against recent isolates of Streptococcus pneumoniae, Moraxella catarrhalis, and Haemophilus influenzae.: A European multi-centre study
    Jones, ME
    Staples, AM
    Critchley, I
    Thornsberry, C
    Heinze, P
    Engler, HD
    Sahm, DF
    [J]. DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2000, 37 (03) : 203 - 211
12345